bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.04.10.717786

General, orders-of-magnitude faster whole-genome analysis with genotype representation graphs

Abstract

Whole-genome sequencing (WGS) of biobank-scale cohorts have generated datasets that traditional tabular genotype formats cannot efficiently store or analyze. Genotype Representation Graphs (GRGs) offer a compelling alternative: a biologically-motivated, hierarchical, graph-based representation that compactly and losslessly encodes the genotypes, and that supports computation directly on the graph rather than on a materialized genotype matrix. Here we introduce two advances that together make GRG a practical foundation for biobank-scale population and statistical genetics. First, we present GRG v2, a substantially improved format and construction algorithm that reduces construction time by 10-20x, halves the disk and RAM footprint of the resulting files, and improves load time by more than 20x. Applied to the recently phased UK Biobank WGS dataset (490,541 individuals, 706,556,181 variants), GRG v2 produces files 25 times smaller than .vcf.gz and more than 8 times smaller than PLINK2s PGEN format, while costing less than 90 GBP to construct. Second, we introduce grapp, a Python library and command-line tool that exploits the computational advantages of GRG for both routine analyses and new method development. grapp provides standard pipelines for variant and sample filtering, genome-wide association studies (GWAS) with covariates, principal component analysis (PCA), and data export, all implemented as graph-based operations. Moreover, it provides linear operators that integrate with the numpy and scipy sparse linear algebra ecosystem, enabling implicit matrix multiplication against the standardized genotype matrix, the linkage disequilibrium matrix, and the genetic relatedness matrix all via an underlying GRG. Using these operators, scipy-based PCA can be implemented in four lines of Python and runs 51-492x faster than existing methods while using less RAM. PCA on 89,988,512 variants in the UK Biobank runs in two to four hours. This scalability allows us to introduce a leave-one-chromosome-out (LOCO) approach to GWAS covariate construction that avoids LD artifacts without requiring LD pruning. Together, GRG v2 and grapp enable a level of scalability and methodological flexibility that is not achievable with traditional genotype formats.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

DeHaas, D., Adonizio, C., Pan, Z., Wei, X.. 2026-04-11. General, orders-of-magnitude faster whole-genome analysis with genotype representation graphs. https://doi.org/10.64898/2026.04.10.717786

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypes

Pathogenic ERCC2 variants cause xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or both, yet variant effect scores are usually interpreted only as measures of pathogenicity rather than of which disease mechanism is disrupted. XPD, the ERCC2-encoded TFIIH subunit, functions in both nucleotide excision repair and transcription. Using yeast complementation deep mutational scanning, we measured the effects of nearly all XPD amino acid substitutions. The assay was mechanism-selective: it preferentially reported transcription-associated function, with pronounced intolerance at the p44 interface, whereas many substitutions affecting DNA binding and helicase activity retained near-wild-type fitness. Accordingly, TTD variants had much lower fitness than XP variants. Computational predictors discriminated pathogenic from benign variants similarly across phenotypes, but the DMS distinguished XP from TTD variants better than all 73 predictors tested. Phenotype-specific ACMG/AMP calibration provided evidence in both directions for TTD but mainly pathogenic evidence for XP. Thus, the selectivity of functional assays, often viewed as a limitation, can reveal disease mechanisms and support phenotype-aware variant interpretation.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗